The Multidisciplinary Association for Psychedelic Studies (MAPS) is a membership-based, IRS-approved 501 (c) (3) non-profit research and educational organization. Our mission is to develop psychedelics and marijuana into legal prescription medicines for therapeutic applications. We are actively developing and funding clinical trials with human subjects in accordance with guidelines set forth by the United States’ Food and Drug Administration, the European Medicines Agency, and the International Council on Harmonization (ICH/GCP). During this process we are training therapists to administer psychedelic drugs in therapeutic settings. One day we will open psychedelic therapy clinics around the world. MAPS is also engaged in efforts to educate people about the benefits and risks of psychedelics and medical marijuana. MAPS relies on the generous support of dues-paying members in order to fund our numerous research projects. Please become a MAPS member today.